Power of Attorney for SEC Reporting Purposes

This filing details a Limited Power of Attorney granted by Peter J. Pitts, a director of BRAINSTORM CELL THERAPEUTICS INC. (BCLI), to Matthew Leder and Joseph Nunziata. This power of attorney authorizes the appointees to act on Mr. Pitts' behalf for SEC reporting requirements, including obtaining EDGAR credentials, managing EDGAR accounts, and executing Forms 3, 4, 5, and 144. The document also covers obtaining information on BCLI securities transactions from third parties and making necessary filings with the SEC and stock exchanges. The power of attorney remains in effect until Mr. Pitts is no longer required to file these forms, unless earlier revoked. Additionally, the filing includes details of a stock option grant to Mr. Pitts, with 150,000 options exercisable at $0.68, vesting in two tranches.